Zdrowie i gospodarka · 18/09/2003

FDA Releases Revised Guidance on Donor Suitability and Blood Product Safety for SARS Cases

The FDA has released a revised guidance document to help blood establishments assess donor suitability and blood product safety in cases of suspected severe acute respiratory syndrome (SARS) or exposure to SARS, effective September 2003.